Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
Hour-by-Hour Action Plan: 48 Hours to Board Meeting Guiding Principle: Patient safety is non-negotiable. Transparency, even when painful, is the only sustainable path. The goal is to act with speed, integrity, and strategic precision to protect patients, the company’s long-term viability, and regulatory trust.Read the full answer
As CEO, I would not wait six months and I would not let the board delay disclosure while patients remain exposed to an unreported serious risk. I would treat this as a patient-safety, regulatory, legal, and trust crisis—not merely a financial-risk issue. My guiding decisions would be: Patient safety comes first.Read the full answer